GLP-1 受容体アゴニストは、食事や運動療法と組み合わせて 2 型糖尿病を治療するために使用される非インスリン製剤の一種です。これらの製剤は、血糖値とヘモグロビン A1C を低下させ、減量を補助するために使用されます。GLP-1 は、食欲と喉の渇きを司る脳の部位である視床下部に、水と食物の消費を減らすよう信号を送ります。2021年における世界のグルカゴン様ペプチド 1 (GLP-1) 市場は 165億3000万ドルと評価され、2027年までに 241億ドルに達する可能性があります。
市場は、糖尿病の治療に役立つ承認された製品の増加によって、今後数年間で勢いを増すでしょうM&Aの増加が、今後数年間で市場を後押しすることが予想されます。GLP-1市場は2022年から 2027 年までの予測期間中に 6.48%のCAGRで成長すると予測されます。
目次
1. Executive Summary
2. Introduction
2.1 Glucagon-like Peptide-1 (GLP-1): An Overview
2.1.1 Definition of Glucagon-like Peptide-1 (GLP-1)
2.1.2 Types of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist
2.2 Glucagon-like Peptide-1 (GLP-1) Segmentation: An Overview
2.2.1 Glucagon-like Peptide-1 (GLP-1) Segmentation
3. Global Market Analysis
3.1 Global Glucagon-like Peptide-1 (GLP-1) Market: An Analysis
3.1.1 Global Glucagon-like Peptide-1 (GLP-1) Market: An Overview
3.1.2 Global Glucagon-like Peptide-1 (GLP-1) Market by Value
3.1.3 Global Glucagon-like Peptide-1 (GLP-1) Market by Product (Trulicity, Ozempic, Victoza, Rybelsus and Other GLP 1 Products)
3.1.4 Global Glucagon-like Peptide-1 (GLP-1) Market by Route of Administration (Injectable and Oral Medication)
3.1.5 Global Glucagon-like Peptide-1 (GLP-1) Market by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa)
3.2 Global Glucagon-like Peptide-1 (GLP-1) Market: Product Analysis
3.2.1 Global Glucagon-like Peptide-1 (GLP-1) Market by Product: An Overview
3.2.2 Global Trulicity GLP-1 Market by Value
3.2.3 Global Ozempic GLP-1 Market by Value
3.2.4 Global Victoza GLP-1 Market by Value
3.2.5 Global Rybelsus GLP-1 Market by Value
3.2.6 Global Other GLP-1 Products Market by Value
4. Regional Market Analysis
4.1 North America Glucagon-like Peptide-1 (GLP-1) Market: An Analysis
4.1.1 North America Glucagon-like Peptide-1 (GLP-1) Market: An Overview
4.1.2 North America Glucagon-like Peptide-1 (GLP-1) Market by Value
4.1.3 North America Glucagon-like Peptide-1 (GLP-1) Market by Region (The US, Canada, and Mexico)
4.1.4 The US Glucagon-like Peptide-1 (GLP-1) Market by Value
4.1.5 The US Glucagon-like Peptide-1 (GLP-1) Market by Route of Administration (Injectable and Oral Medication)
4.1.6 Canada Glucagon-like Peptide-1 (GLP-1) Market by Value
4.1.7 Mexico Glucagon-like Peptide-1 (GLP-1) Market by Value
4.2 Europe Glucagon-like Peptide-1 (GLP-1) Market: An Analysis
4.2.1 Europe Glucagon-like Peptide-1 (GLP-1) Market: An Overview
4.2.2 Europe Glucagon-like Peptide-1 (GLP-1) Market by Value
4.2.3 Europe Glucagon-like Peptide-1 (GLP-1) Market by Region (Germany, The UK, France, Italy, Spain, and Rest of the Europe)
4.2.4 Germany Glucagon-like Peptide-1 (GLP-1) Market by Value
4.2.5 The UK Glucagon-like Peptide-1 (GLP-1) Market by Value
4.2.6 France Glucagon-like Peptide-1 (GLP-1) Market by Value
4.2.7 Italy Glucagon-like Peptide-1 (GLP-1) Market by Value
4.2.8 Spain Glucagon-like Peptide-1 (GLP-1) Market by Value
4.2.9 Rest of Europe Glucagon-like Peptide-1 (GLP-1) Market by Value
4.3 Asia Pacific Glucagon-like Peptide-1 (GLP-1) Market: An Analysis
4.3.1 Asia Pacific Glucagon-like Peptide-1 (GLP-1) Market: An Overview
4.3.2 Asia Pacific Glucagon-like Peptide-1 (GLP-1) Market by Value
4.3.3 Asia Pacific Glucagon-like Peptide-1 (GLP-1) Market by Region (China, Japan, India, Australia, South Korea, and Rest of the Asia Pacific)
4.3.4 China Glucagon-like Peptide-1 (GLP-1) Market by Value
4.3.5 Japan Glucagon-like Peptide-1 (GLP-1) Market by Value
4.3.6 India Glucagon-like Peptide-1 (GLP-1) Market by Value
4.3.7 Australia Glucagon-like Peptide-1 (GLP-1) Market by Value
4.3.8 South Korea Glucagon-like Peptide-1 (GLP-1) Market by Value
4.3.9 Rest of Asia Pacific Glucagon-like Peptide-1 (GLP-1) Market by Value
4.4 Latin America Glucagon-like Peptide-1 (GLP-1) Market: An Analysis
4.4.1 Latin America Glucagon-like Peptide-1 (GLP-1) Market: An Overview
4.4.2 Latin America Glucagon-like Peptide-1 (GLP-1) Market by Value
4.5 Middle East & Africa Glucagon-like Peptide-1 (GLP-1) Market: An Analysis
4.5.1 Middle East & Africa Glucagon-like Peptide-1 (GLP-1) Market: An Overview
4.5.2 Middle East & Africa Glucagon-like Peptide-1 (GLP-1) Market by Value
5. Impact of COVID
5.1 Impact of COVID-19
5.1.1 Impact of COVID-19 on Healthcare
5.1.2 Impact of COVID-19 on Glucagon-like Peptide-1 (GLP-1) Market
6. Market Dynamics
6.1 Growth Driver
6.1.1 Rising Cases of Diabetes
6.1.2 Rising Cases of Obesity
6.1.3 Rapid Urbanization
6.1.4 Increasing Healthcare Expenditure
6.1.5 Increasing Aging Population
6.2 Challenges
6.2.1 Short Half-Life of Glucagon-like Peptide 1 (GLP-1) Receptor Agonists
6.2.2 Unknown Severe Side Effects
6.3 Market Trends
6.3.1 Potential Clinical Application of GLP-1 Receptor Agonists For the Treatment of NASH
6.3.2 Surge in Research & Development in Pharmaceutical Sector
6.3.3 New Product Launches
6.3.4 Expanding Reimbursement Landscape
7. Competitive Landscape
7.1 Global Glucagon-like Peptide 1 (GLP-1) Players by Market Share
7.2 Global Glucagon-like Peptide 1 (GLP-1) Market Players: Product Comparison
8. Company Profiles
8.1 Sanofi
8.1.1 Business Overview
8.1.2 Operating Segments
8.1.3 Business Strategies
8.2 Pfizer Inc.
8.2.1 Business Overview
8.2.2 Operating Segments
8.2.3 Business Strategies
8.3 AstraZeneca PLC
8.3.1 Business Overview
8.3.2 Operating Regions
8.3.3 Business Strategy
8.4 Eli Lilly and Company
8.4.1 Business Overview
8.4.2 Operating Products
8.4.3 Business Strategy
8.5 Novo Nordisk A/S
8.5.1 Business Overview
8.5.2 Operating Segments
8.5.3 Business Strategy
8.6 Shanghai Benemae Pharmaceutical Corporation
8.6.1 Business Overview
8.6.2 Business Strategy
8.7 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
8.7.1 Business Overview
8.7.2 Business Strategy
List of Figures
Figure 1: Types of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist
Figure 2: Glucagon-like Peptide-1 (GLP-1) Segmentation by Product
Figure 3: Global Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Billion)
Figure 4: Global Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Billion)
Figure 5: Global Glucagon-like Peptide-1 (GLP-1) Market by Product; 2021 (Percentage, %)
Figure 6: Global Glucagon-like Peptide-1 (GLP-1) Market by Route of Administration; 2021 (Percentage, %)
Figure 7: Global Glucagon-like Peptide-1 (GLP-1) Market by Region; 2021 (Percentage, %)
Figure 8: Global Trulicity GLP-1 Market by Value; 2017-2021 (US$ Billion)
Figure 9: Global Trulicity GLP-1 Market by Value; 2022-2027 (US$ Billion)
Figure 10: Global Ozempic GLP-1 Market by Value; 2017-2021 (US$ Billion)
Figure 11: Global Ozempic GLP-1 Market by Value; 2022-2027 (US$ Billion)
Figure 12: Global Victoza GLP-1 Market by Value; 2017-2021 (US$ Billion)
Figure 13: Global Victoza GLP-1 Market by Value; 2022-2027 (US$ Billion)
Figure 14: Global Rybelsus GLP-1 Market by Value; 2017-2021 (US$ Million)
Figure 15: Global Rybelsus GLP-1 Market by Value; 2022-2027 (US$ Billion)
Figure 16: Global Other GLP-1 Products Market by Value; 2017-2021 (US$ Billion)
Figure 17: Global Other GLP-1 Products Market by Value; 2022-2027 (US$ Billion)
Figure 18: North America Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Billion)
Figure 19: North America Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Billion)
Figure 20: North America Glucagon-like Peptide-1 (GLP-1) Market by Region; 2021 (Percentage, %)
Figure 21: The US Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Billion)
Figure 22: The US Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Billion)
Figure 23: The US Glucagon-like Peptide-1 (GLP-1) Market by Route of Administration; 2021 (Percentage, %)
Figure 24: Canada Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Million)
Figure 25: Canada Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Billion)
Figure 26: Mexico Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Million)
Figure 27: Mexico Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Million)
Figure 28: Europe Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Billion)
Figure 29: Europe Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Billion)
Figure 30: Europe Glucagon-like Peptide-1 (GLP-1) Market by Region; 2021 (Percentage, %)
Figure 31: Germany Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Billion)
Figure 32: Germany Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Billion)
Figure 33: The UK Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Million)
Figure 34: The UK Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Billion)
Figure 35: France Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Million)
Figure 36: France Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Million)
Figure 37: Italy Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Million)
Figure 38: Italy Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Million)
Figure 39: Spain Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Million)
Figure 40: Spain Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Million)
Figure 41: Rest of Europe Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Million)
Figure 42: Rest of Europe Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Million)
Figure 43: Asia Pacific Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Billion)
Figure 44: Asia Pacific Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Billion)
Figure 45: Asia Pacific Glucagon-like Peptide-1 (GLP-1) Market by Region; 2021 (Percentage, %)
Figure 46: China Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Million)
Figure 47: China Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Billion)
Figure 48: Japan Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Million)
Figure 49: Japan Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Billion)
Figure 50: India Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Million)
Figure 51: India Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Million)
Figure 52: Australia Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Million)
Figure 53: Australia Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Million)
Figure 54: South Korea Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Million)
Figure 55: South Korea Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Million)
Figure 56: Rest of Asia Pacific Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Million)
Figure 57: Rest of Asia Pacific Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Million)
Figure 58: Latin America Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Million)
Figure 59: Latin America Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Billion)
Figure 60: Middle East & Africa Glucagon-like Peptide-1 (GLP-1) Market by Value; 2017-2021 (US$ Million)
Figure 61: Middle East & Africa Glucagon-like Peptide-1 (GLP-1) Market by Value; 2022-2027 (US$ Billion)
Figure 62: Global Number of People with Diabetes in Adults (20-79 Years) by Region; 2021 & 2045 (Million)
Figure 63: Global Numbers Of People with Obesity and Severe Obesity, 2010-2030 (Million)
Figure 64: Global Urban Population; 2017-2021 (Percentage, %)
Figure 65: The US, Sweden and Norway Health Spending Per Capita; 2017-2021 (US$ Million)
Figure 66: Global Percentage of Population Aged 65 Years or Over; 2022, 2030 & 2050 (Percentage, %)
Figure 67: NASH Prevalence and Diagnosed Cases; 2021 & 2030 (Million)
Figure 68: Global Pharmaceutical Research and Development Spending; 2019-2028 (US$ Billion)
Figure 69: Global Glucagon-like Peptide 1 (GLP-1) Players by Market Share; 2021 (Percentage, %)
Figure 70: Sanofi Net Sales by Segments; 2021 (Percentage, %)
Figure 71: Pfizer Inc. Revenues by Operating Segments; 2021 (Percentage, %)
Figure 72: AstraZeneca PLC Revenue by Geographical Region; 2021 (Percentage, %)
Figure 73: Eli Lilly and Company Revenue by Products; 2021 (Percentage, %)
Figure 74: Novo Nordisk A/S Net Sales by Segment; 2021 (Percentage, %)
Table 1: Global Glucagon-like Peptide 1 (GLP-1) Market Players: Product Comparison
